Position in EXEL
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$16,262,224
-$968,747 QoQ
Shares Held
298,883
-25.6% QoQ
Ownership
0.121%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#103
of 739 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 15%
Shared 0%
None 85%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026INTECH INVESTMENT MANAGEMENT LLC holds $203,392,281 across 193 Biotechnology names. EXEL ranks #1 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
This page
|
298,883 | $16,262,224 | |
| 2 | INCY |
Incyte Corp
|
141,278 | $16,015,273 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,260 | $13,879,999 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
162,292 | $12,702,594 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
36,760 | $11,065,862 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
20,520 | $10,192,899 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
37,384 | $9,008,422 | |
| 8 | TGTX |
Tg Therapeutics, Inc.
|
124,646 | $6,848,051 |
All Filings in EXEL
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,262,224 | 298,883 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $17,230,971 | 401,748 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $12,803,356 | 292,114 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $24,813,494 | 600,811 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $19,894,538 | 451,328 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $14,473,452 | 392,022 | Shares | Sole | 2025-05-20 | |
| 2024-12-31 | $8,915,242 | 267,725 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $6,021,463 | 232,041 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $3,517,723 | 156,552 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,373,925 | 100,039 | Shares | Sole | 2024-08-02 | |
| 2023-12-31 | $938,344 | 39,114 | Shares | Sole | 2024-10-18 | |
| 2023-09-30 | $830,321 | 38,001 | Shares | Sole | 2024-10-18 | |
| 2023-06-30 | $1,013,021 | 53,010 | Shares | Sole | 2024-10-18 | |
| 2023-03-31 | $1,731,216 | 89,192 | Shares | Sole | 2024-10-18 | |
| 2022-12-31 | $1,913,748 | 119,311 | Shares | Sole | 2024-10-18 | |
| 2022-09-30 | $2,088,434 | 133,191 | Shares | Sole | 2024-10-18 | |
| No filing history on record for this holder in this stock. | ||||||